Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
US FDA approves Adaptimmune's gene therapy for rare type of cancer
ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company